 Amy Yu
Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Transfer | 7 | 2026 | 211 | 3.740 |
Why?
| | Health Physics | 2 | 2026 | 7 | 1.200 |
Why?
| | Hospitalists | 6 | 2026 | 267 | 0.910 |
Why?
| | Qualitative Research | 8 | 2025 | 1674 | 0.880 |
Why?
| | Personnel Selection | 1 | 2026 | 91 | 0.860 |
Why?
| | Workload | 1 | 2025 | 168 | 0.780 |
Why?
| | Trust | 1 | 2025 | 155 | 0.780 |
Why?
| | Triage | 1 | 2026 | 250 | 0.780 |
Why?
| | Physicians | 3 | 2026 | 955 | 0.620 |
Why?
| | Fibrinolytic Agents | 3 | 2026 | 297 | 0.580 |
Why?
| | Thrombolytic Therapy | 3 | 2025 | 164 | 0.470 |
Why?
| | Internship and Residency | 1 | 2026 | 1267 | 0.450 |
Why?
| | Thrombectomy | 2 | 2025 | 78 | 0.420 |
Why?
| | Stroke | 4 | 2026 | 1270 | 0.400 |
Why?
| | Academic Medical Centers | 4 | 2025 | 554 | 0.380 |
Why?
| | Focus Groups | 5 | 2025 | 569 | 0.340 |
Why?
| | Interviews as Topic | 2 | 2025 | 910 | 0.330 |
Why?
| | Tissue Plasminogen Activator | 2 | 2026 | 248 | 0.260 |
Why?
| | Humans | 30 | 2026 | 145474 | 0.250 |
Why?
| | Pentosyltransferases | 1 | 2026 | 7 | 0.250 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2026 | 26 | 0.250 |
Why?
| | Optic Atrophy, Hereditary, Leber | 1 | 2026 | 9 | 0.240 |
Why?
| | Rhabdomyosarcoma | 1 | 2026 | 65 | 0.230 |
Why?
| | Nucleotides | 1 | 2026 | 129 | 0.230 |
Why?
| | Copper | 1 | 2026 | 119 | 0.230 |
Why?
| | Intracranial Hemorrhages | 1 | 2026 | 106 | 0.220 |
Why?
| | Morals | 1 | 2026 | 78 | 0.220 |
Why?
| | Loneliness | 1 | 2025 | 67 | 0.220 |
Why?
| | Middle Aged | 13 | 2026 | 36215 | 0.210 |
Why?
| | Metadata | 1 | 2024 | 17 | 0.210 |
Why?
| | Polypharmacy | 1 | 2025 | 94 | 0.210 |
Why?
| | Mood Disorders | 1 | 2025 | 143 | 0.210 |
Why?
| | Health Information Exchange | 1 | 2024 | 23 | 0.210 |
Why?
| | Neuroimaging | 1 | 2026 | 297 | 0.200 |
Why?
| | Central Nervous System Neoplasms | 1 | 2026 | 177 | 0.200 |
Why?
| | Leadership | 3 | 2025 | 401 | 0.200 |
Why?
| | Fatigue | 1 | 2025 | 364 | 0.190 |
Why?
| | Publishing | 1 | 2024 | 114 | 0.190 |
Why?
| | Female | 19 | 2026 | 78844 | 0.190 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2026 | 297 | 0.190 |
Why?
| | Brain Ischemia | 1 | 2026 | 359 | 0.180 |
Why?
| | Male | 17 | 2026 | 72842 | 0.180 |
Why?
| | Adult | 9 | 2026 | 40777 | 0.180 |
Why?
| | Teaching | 1 | 2024 | 237 | 0.180 |
Why?
| | Time-to-Treatment | 1 | 2024 | 251 | 0.180 |
Why?
| | Clinical Decision-Making | 1 | 2025 | 363 | 0.170 |
Why?
| | Epigenesis, Genetic | 1 | 2026 | 679 | 0.170 |
Why?
| | Emergency Service, Hospital | 2 | 2025 | 2381 | 0.170 |
Why?
| | Social Determinants of Health | 1 | 2025 | 308 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2025 | 272 | 0.170 |
Why?
| | Hospice Care | 1 | 2023 | 227 | 0.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2026 | 1443 | 0.160 |
Why?
| | Home Care Services | 1 | 2023 | 284 | 0.160 |
Why?
| | Inpatients | 1 | 2024 | 553 | 0.160 |
Why?
| | Patient Safety | 1 | 2024 | 356 | 0.150 |
Why?
| | Biomarkers, Tumor | 1 | 2026 | 1321 | 0.150 |
Why?
| | Mitochondria | 1 | 2026 | 992 | 0.150 |
Why?
| | Endovascular Procedures | 1 | 2024 | 390 | 0.150 |
Why?
| | Hospital Medicine | 1 | 2021 | 97 | 0.150 |
Why?
| | Electronic Health Records | 2 | 2024 | 1196 | 0.140 |
Why?
| | Registries | 2 | 2025 | 2406 | 0.140 |
Why?
| | Cytokines | 1 | 2026 | 2067 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 735 | 0.140 |
Why?
| | Insulinoma | 1 | 2018 | 29 | 0.140 |
Why?
| | Confusion | 1 | 2018 | 30 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 195 | 0.130 |
Why?
| | Medicare | 1 | 2023 | 903 | 0.130 |
Why?
| | Hospitals | 1 | 2022 | 732 | 0.120 |
Why?
| | Pandemics | 2 | 2026 | 1707 | 0.120 |
Why?
| | Aged | 9 | 2026 | 26153 | 0.120 |
Why?
| | Attitude of Health Personnel | 1 | 2024 | 1193 | 0.120 |
Why?
| | United States | 4 | 2026 | 16098 | 0.110 |
Why?
| | Hospitalization | 2 | 2023 | 2460 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1969 | 0.110 |
Why?
| | Surveys and Questionnaires | 5 | 2026 | 6066 | 0.110 |
Why?
| | Aged, 80 and over | 5 | 2026 | 8333 | 0.110 |
Why?
| | Cognition Disorders | 1 | 2018 | 541 | 0.100 |
Why?
| | Canada | 2 | 2025 | 431 | 0.100 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2026 | 934 | 0.100 |
Why?
| | Patient Care Team | 1 | 2019 | 696 | 0.100 |
Why?
| | Patient Discharge | 1 | 2019 | 992 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1581 | 0.080 |
Why?
| | Treatment Outcome | 4 | 2026 | 11772 | 0.080 |
Why?
| | Heart Failure | 1 | 2023 | 2326 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 928 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2026 | 3542 | 0.070 |
Why?
| | Patient Readmission | 2 | 2026 | 769 | 0.060 |
Why?
| | Length of Stay | 2 | 2026 | 1349 | 0.060 |
Why?
| | Observational Studies as Topic | 1 | 2026 | 133 | 0.060 |
Why?
| | Computed Tomography Angiography | 1 | 2026 | 146 | 0.050 |
Why?
| | Methotrexate | 1 | 2026 | 233 | 0.050 |
Why?
| | California | 1 | 2026 | 471 | 0.050 |
Why?
| | Job Satisfaction | 1 | 2026 | 237 | 0.050 |
Why?
| | Writing | 1 | 2024 | 101 | 0.050 |
Why?
| | Anxiety Disorders | 1 | 2025 | 369 | 0.050 |
Why?
| | Recovery of Function | 1 | 2026 | 716 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2026 | 1246 | 0.040 |
Why?
| | Periodicals as Topic | 1 | 2024 | 209 | 0.040 |
Why?
| | DNA Methylation | 1 | 2026 | 674 | 0.040 |
Why?
| | Faculty | 1 | 2021 | 147 | 0.040 |
Why?
| | Schools, Medical | 1 | 2021 | 159 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2026 | 1747 | 0.040 |
Why?
| | Mice | 2 | 2026 | 18329 | 0.040 |
Why?
| | Mentors | 1 | 2021 | 217 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2019 | 64 | 0.030 |
Why?
| | Age Factors | 1 | 2026 | 3342 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2953 | 0.030 |
Why?
| | Communication | 1 | 2024 | 975 | 0.030 |
Why?
| | Schools | 1 | 2021 | 448 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 200 | 0.030 |
Why?
| | Child | 2 | 2026 | 22707 | 0.030 |
Why?
| | Quality Improvement | 1 | 2024 | 1295 | 0.030 |
Why?
| | Telemedicine | 1 | 2024 | 961 | 0.030 |
Why?
| | Animals | 2 | 2026 | 38030 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2026 | 3904 | 0.020 |
Why?
| | Child, Preschool | 1 | 2026 | 11853 | 0.020 |
Why?
| | Young Adult | 1 | 2026 | 14218 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 10885 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4553 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2769 | 0.020 |
Why?
| | Adolescent | 1 | 2026 | 22529 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2023 | 17291 | 0.010 |
Why?
|
|
Yu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|